Symptomatic Stable Angina Pectoris
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients clinically diagnosed with symptomatic stable angina pectoris Aged 20 years or older and under 85 years at the time of obtaining informed consent Physically suitable for both cardiac CT and PET examinations, and able to undergo pharmacologic stress testing (e.g., adenosine) Provided written informed consent after receiving adequate explanation of the study
Exclusion criteria
Exclusion criteria: Patients with obesity that may cause technical difficulty or significant image degradation (e.g., BMI > 35) Patients with significant arrhythmias (e.g., frequent premature beats or atrial fibrillation) that preclude stable ECG gating, as judged by the investigator Pregnant or breastfeeding women Patients with severe renal dysfunction (eGFR < 30 mL/min/1.73m2) Patients with severe hepatic dysfunction (equivalent to Child-Pugh class C) Patients with a history of severe allergy to iodinated contrast agents or pharmacologic stress agents (e.g., adenosine) Patients with clinically significant comorbidities (e.g., acute heart failure) that make participation unsafe Patients deemed inappropriate for participation by the principal investigator or sub-investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Pearson correlation coefficient and Bland-Altman agreement between coronary flow reserve (CFR) values derived from photon-counting CT and those obtained by N-13 ammonia PET. | — |
Countries
Japan
Contacts
Institute of Science Tokyo Hospital Department of cardiology